NEW YORK, NY, UNITED STATES, January 6, 2026 / EINPresswire.com / — Panther Life Sciences announces expanded access to its ...

As they prepare for the J.P. Morgan Healthcare Conference next week, biotech leaders and analysts say companies are better ...

For the first time, scientists have answered a longstanding question in cell biology about a partnership of proteins called ...

A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital ...

GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th ...

Serán Bioscience, LLC,  in collaboration with leading developer and design-builder Mortenson, hosted a topping-out ceremony ...

Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...

Europe needs a new system compelling researchers, governments and companies to share risk from the earliest stages of therapy ...

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.

The TIGIT inhibitors market is poised for growth with the anticipated drug approval by 2030, over 40 drugs in clinical trials, and a dynamic landscape involving major pharmaceutical and biotech firms.

Rakuten Medical has added to its tally of mega-rounds, pocketing another $100 million to push its lead light-based cancer ...

Nizwa: A landmark research project on the development of a 3D-bioprinted wound dressing in the health sector has secured ...